Folgen
rudy schreiber
rudy schreiber
Assistant Professor, Maastricht University
Bestätigte E-Mail-Adresse bei maastrichtuniversity.nl - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance
FG Boess, M Hendrix, FJ van der Staay, C Erb, R Schreiber, ...
Neuropharmacology 47 (7), 1081-1092, 2004
3772004
Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action
J De Vry, R Schreiber
Neuroscience & Biobehavioral Reviews 24 (3), 341-353, 2000
2262000
(1-(2, 5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C …
R Schreiber, M Brocco, V Audinot, A Gobert, S Veiga, MJ Millan
Journal of Pharmacology and Experimental Therapeutics 273 (1), 101-112, 1995
2231995
Improving memory: a role for phosphodiesterases
A Blokland, R Schreiber, J Prickaerts
Current pharmaceutical design 12 (20), 2511-2523, 2006
2172006
AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors
M Van Kampen, K Selbach, R Schneider, E Schiegel, F Boess, ...
Psychopharmacology 172, 375-383, 2004
2142004
Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders
W Spooren, T Ballard, F Gasparini, M Amalric, V Mutel, R Schreiber
Behavioural pharmacology 14 (4), 257-277, 2003
2142003
Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs
J De Vry, U Benz, R Schreiber, J Traber
European journal of pharmacology 249 (3), 331-339, 1993
2041993
5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action?
R Schreiber, J De Vry
Progress in Neuro-Psychopharmacology and Biological Psychiatry 17 (1), 87-104, 1993
1851993
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the ‘atypical’antipsychotics, clozapine and risperidone
R Schreiber, M Brocco, MJ Millan
European journal of pharmacology 264 (1), 99-102, 1994
1831994
Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat
R Schreiber, J De Vry
European journal of pharmacology 249 (3), 341-351, 1993
1671993
Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
T Jolas, R Schreiber, AM Laporte, M Chastanet, J De Vry, T Glaser, ...
Journal of Pharmacology and Experimental Therapeutics 272 (2), 920-929, 1995
1641995
The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat
CKJ Lieben, A Blokland, A Şık, E Sung, P van Nieuwenhuizen, ...
Neuropsychopharmacology 30 (12), 2169-2179, 2005
1512005
Comparison of hypericum extracts with imipramine and fluoxetine in animal models of depression and alcoholism
J De Vry, S Maurel, R Schreiber, R De Beun, KR Jentzsch
European Neuropsychopharmacology 9 (6), 461-468, 1999
1211999
5-HT1A receptors are differentially involved in the anxiolytic-and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat
J De Vry, R Schreiber, C Melon, M Dalmus, KR Jentzsch
European Neuropsychopharmacology 14 (6), 487-495, 2004
1142004
Effects of α4/β2-and α7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice
R Schreiber, M Dalmus, J De Vry
Psychopharmacology 159 (3), 248-257, 2002
1062002
Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders
J Spaas, L Van Veggel, M Schepers, A Tiane, J Van Horssen, ...
Cellular and Molecular Life Sciences 78 (10), 4615-4637, 2021
1042021
The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test
R Schreiber, C Melon, J De Vry
Psychopharmacology 135, 383-391, 1998
1031998
Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT1A receptor activation
R Schreiber, A Newman-Tancredi
Neurobiology of learning and memory 110, 72-80, 2014
992014
5-HT1A Receptors in Anxiety
J De Vry, T Glaser, T Schuurman, R Schreiber, J Traber
New concepts in anxiety, 94-129, 1991
991991
S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT) 1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties
MJ Millan, S Hjorth, R Samanin, R Schreiber, R Jaffard, ...
Journal of Pharmacology and Experimental Therapeutics 282 (1), 148-161, 1997
971997
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20